Is OCX a buy or a sell?
The Discounted Cash Flow (DCF) valuation of OncoCyte Corp (OCX) is (201.59) USD. With the latest stock price at 3.04 USD, the upside of OncoCyte Corp based on DCF is -6731.4%. This means that OCX is a sell according to the DCF valuation model.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 8.3% | 6.7% |
| Long-term Growth Rate | 3.0% - 4.9% | 3.9% |
| Fair Price | (2,225.31) - (106.36) | (201.59) |
| Upside | -73301.1% - -3598.6% | -6731.4% |